Pharmaceutical News

RSS

Study confirms esaxerenone as a safe and effective alternative for hypertension treatment

Researchers find that esaxerenone is a non-inferior alternative to trichlormethiazide for treating uncontrolled hypertension in Japanese patients. The study confirms similar safety profiles for both drugs.

25 Jul 2024

Opioid use disorder medications underused after injection-related infections

Deaths from injection-related infections like endocarditis have increased among young people, likely due to the growth of injection drug use and stronger, shorter-acting fentanyl.

24 Jul 2024

High-risk NSAID prescriptions cost NHS £31 million

Prescribing non-steroidal anti-inflammatory drugs (NSAIDs) to people at high risk of harm from them is estimated to cost the NHS in England around £31 million and cause more than 6,000 lost years of good health over 10 years, finds a study published by The BMJ today.

24 Jul 2024

Older adults show interest in deprescribing, study reveals

More than 82% of Americans age 50 to 80 take one or more kinds of prescription medication, and 80% of them say they'd be open to stopping one or more of those drugs if their health care provider gave the green light, a new University of Michigan study shows.

24 Jul 2024

World-famous wall drug isn’t immune from challenges facing rural pharmacies

Stacey Schulz parks in a rear lot to avoid the crowded Main Street entrances to her local pharmacy.

24 Jul 2024

Louisiana reclassifies drugs used in abortions as controlled dangerous substances

Louisiana lawmakers have added two drugs commonly used in pregnancy and reproductive health care to the state's list of controlled dangerous substances, a move that has alarmed doctors in the state.

24 Jul 2024

Study warns of medication expiry risk for Mars-bound astronauts

Medications used by astronauts on the International Space Station might not be good enough for a three-year journey to Mars.

23 Jul 2024

Why millions are trying FDA-authorized alternatives to big pharma’s weight loss drugs

Pharmacist Mark Mikhael has lost 50 pounds over the past 12 months. He no longer has diabetes and finds himself "at my ideal body weight," with his cholesterol below 200 for the first time in 20 years. "I feel fantastic," he said.

23 Jul 2024

Beyond the anti-obesity benefits of glucagon-like peptide-1 drugs

The advantages of glucagon-like peptide-1 (GLP-1) medicines beyond glycemic and weight control.

23 Jul 2024

COVID vaccines and infections in early pregnancy show no increased risk of birth defects in large Nordic study

Research on 343,066 infants across Denmark, Sweden, and Norway shows no increased risk of congenital anomalies from COVID-19 infections or vaccinations during the first trimester. The study confirms safety, supporting vaccination recommendations for pregnant women.

22 Jul 2024

Study identifies trends in the use of glucagon-like peptide-1 receptor agonists

Investigators at Cedars-Sinai and other institutions conducted a nationwide, population-based study to identify trends in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) - prescription medications sold under popular drug names like Ozempic and Wegovy - in the United States.

22 Jul 2024

Understanding the role of structural racism in newborn drug testing practices

Black birthing parents and their newborns disproportionately experience newborn drug testing for prenatal substance exposure by health care professionals.

22 Jul 2024

Efficacy and safety of nirmatrelvir/ritonavir in treating COVID-19: A systematic review

SARS-CoV-2, the virus responsible for the COVID-19 pandemic, remains in circulation.

22 Jul 2024

Combination therapy incorporating three existing drugs shows potential for treating retinal degenerations

Drug repurposing shows promise in the treatment of retinal degenerations, according to a new study by an international team of researchers, published in Nature Communications.

22 Jul 2024

Breakthrough malaria vaccines RTS,S and R21 poised to save thousands of lives

Research paper reviews the efficacy of the first licensed malaria vaccines, RTS,S and R21, highlighting their potential to significantly reduce childhood mortality and discussing future vaccine development strategies.

21 Jul 2024

FDA approval of lifileucel: A milestone in tumor-infiltrating lymphocyte therapy for advanced melanoma

The recent U.S. Food and Drug Administration approval of lifileucel, the first commercial tumor-infiltrating lymphocyte (TIL) therapy for advanced melanoma, marks a significant breakthrough in cancer therapy.

18 Jul 2024

Exploring the expanding horizons of GLP-1 therapies beyond diabetes and obesity

In a Perspective, Daniel Drucker highlights the growing body of evidence that hints at the potential of glucagon-like peptide-1 (GLP-1)-based medications in treating conditions other than diabetes and obesity, including cardiovascular disease and neurodegenerative disorders.

18 Jul 2024

New drugs show promise in shrinking breast cancer brain metastases

Researchers from Drexel's College of Medicine have identified new drugs that show early success in shrinking breast cancer tumors that have metastasized in the brain.

18 Jul 2024

Common blood thinner can be repurposed as an inexpensive antidote for cobra venom

Scientists at the University of Sydney and Liverpool School of Tropical Medicine have made a remarkable discovery: a commonly used blood thinner, heparin, can be repurposed as an inexpensive antidote for cobra venom.

18 Jul 2024

Cystic fibrosis drug reduces hyper-inflammation in COVID-19 pneumonia patients

A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections, according to clinical trial results from researchers at UCL, UCLH and the Francis Crick Institute.

18 Jul 2024

Previous
1
...
19
20
21
22
23
24
25
...
1443
Next

Pharmaceutical News

Study confirms esaxerenone as a safe and effective alternative for hypertension treatment

Opioid use disorder medications underused after injection-related infections

High-risk NSAID prescriptions cost NHS £31 million

Older adults show interest in deprescribing, study reveals

World-famous wall drug isn’t immune from challenges facing rural pharmacies

Louisiana reclassifies drugs used in abortions as controlled dangerous substances

Study warns of medication expiry risk for Mars-bound astronauts

Why millions are trying FDA-authorized alternatives to big pharma’s weight loss drugs

Beyond the anti-obesity benefits of glucagon-like peptide-1 drugs

COVID vaccines and infections in early pregnancy show no increased risk of birth defects in large Nordic study

Study identifies trends in the use of glucagon-like peptide-1 receptor agonists

Understanding the role of structural racism in newborn drug testing practices

Efficacy and safety of nirmatrelvir/ritonavir in treating COVID-19: A systematic review

Combination therapy incorporating three existing drugs shows potential for treating retinal degenerations

Breakthrough malaria vaccines RTS,S and R21 poised to save thousands of lives

FDA approval of lifileucel: A milestone in tumor-infiltrating lymphocyte therapy for advanced melanoma

Exploring the expanding horizons of GLP-1 therapies beyond diabetes and obesity

New drugs show promise in shrinking breast cancer brain metastases

Common blood thinner can be repurposed as an inexpensive antidote for cobra venom

Cystic fibrosis drug reduces hyper-inflammation in COVID-19 pneumonia patients

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News